The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of intensified preoperative management of locally advanced gastrorsophageal junction cancer (INPROVE).
 
Sara Torresan
No Relationships to Disclose
 
Martina Bortolot
No Relationships to Disclose
 
Marco de Scordilli
No Relationships to Disclose
 
Roberto Innocente
No Relationships to Disclose
 
Arianna Fumagalli
Travel, Accommodations, Expenses - PharmaMar
 
Luisa Foltran
No Relationships to Disclose
 
Michela Guardascione
No Relationships to Disclose
 
Paola Di Nardo
Travel, Accommodations, Expenses - Pfizer
 
Elena Ongaro
No Relationships to Disclose
 
Claudia Noto
No Relationships to Disclose
 
Simone Rota
No Relationships to Disclose
 
Brenno Pastò
No Relationships to Disclose
 
Renato Cannizzaro
No Relationships to Disclose
 
Federico Navarria
Travel, Accommodations, Expenses - Boehringer Mannheim Italy; PharmaMar
 
Massimo Vecchiato
No Relationships to Disclose
 
Paolo Ubiali
No Relationships to Disclose
 
Claudio Belluco
No Relationships to Disclose
 
Roberto Petri
No Relationships to Disclose
 
Alessandra Guglielmi
No Relationships to Disclose
 
Fabio Puglisi
Honoraria - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - AstraZeneca; Eisai; Roche
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Lilly; MSD; Novartis; Pfizer; Roche; Seagen